A Randomised, Multi-centre, Double-blind, Active-controlled, Parallel Group Study to Assess the Efficacy and Safety of Modified Release Prednisone (Lodotra®) Compared to Immediate Release Prednisone (Prednisone IR) in Subjects Suffering From Polymyalgia Rheumatica (PMR).
Phase of Trial: Phase III
Latest Information Update: 11 Nov 2015
At a glance
- Drugs Prednisone (Primary)
- Indications Polymyalgia rheumatica
- Focus Registrational; Therapeutic Use
- Sponsors Mundipharma Research
- 01 Apr 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 20 Feb 2014 Status changed from recruiting to active, no longer recruiting reported by ClinicalTrials.gov record.
- 26 Mar 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health: NCT01821040).